Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 clinical trial assessing high-dose Vitamin A palmitate supplementation for Retinitis Pigmentosa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • retinyl palmitate (retinyl palmitate)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Retinitis Pigmentosa | Phase 1 | Status: COMPLETED